# Cambridge Cognition Holdings Plc Appoints Debra Leeves as a Non-Executive Director

- Link: https://www.directorstalkinterviews.com/cambridge-cognition-holdings-plc-appoints-debra-leeves-as-a-non-executive-director/412786470
- Published: 2019-07-01T07:05:58+01:00
- Author: Giles Arbor

The neuroscience technology company, **Cambridge Cognition Holdings plc** ([LON: COG](https://www.directorstalkinterviews.com/company/cambridge-cognition-holdings-plc/cog.l)),
which develops and markets neuroscience technologies to assess brain health, has
today announced the appointment of Debra Leeves as a Non-Executive Director with
immediate effect.

Debra is currently CEO of Vertual, the leading provider of virtual and augmented
reality training simulation systems in radiotherapy. She has over 25 years of experience
in the medical technology and biotechnology industries, and has previously been 
COO of Beckley Canopy Therapeutics, CEO of Physeon and also held senior roles with
companies such as Rex Bionics, Avita Medical, Merck, [GlaxoSmithKline](https://www.directorstalkinterviews.com/ftse-company/glaxosmithkline-plc/gsk.l),
GE Healthcare and Pfizer.

**Matthew Stork, CEO of Cambridge Cognition Holdings said:**

> “We are delighted that Debra has joined the Board. Debra brings with her an immense
> amount of knowledge and expertise in successful global medical technology businesses
> and clinical trial management within major pharmaceutical companies. Her experience
> will be invaluable as we continue the growth of Cambridge Cognition.”

As at the date of this announcement, Mrs Leeves is not beneficially interested in
any Ordinary Shares in the Company.

Share on: